-
Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals
Sep 9, 2025, 16:22 PM -
Exploring Methodologies for Defining and Modeling Cure in Melanoma: Impacts on Estimating Cure Metrics
Sep 9, 2025, 16:22 PM -
Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Targeted Review of mITT vs. ITT Data in CAR-T Submissions
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Analysis of Clinical and Economic Evidence Focused on RWE in Medicare Drug Price Negotiations: Sacubitril/Valsartan, Rivaroxaban, and Apixaban
Sep 9, 2025, 16:22 PM -
Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches
Sep 9, 2025, 16:22 PM -
COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States
Sep 9, 2025, 16:22 PM -
Spinal Muscular Atrophy Treatments in France: What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations
Sep 9, 2025, 16:22 PM -
Standardizing Healthtech Evidence to Meet NICE Expectations
Sep 9, 2025, 16:22 PM -
Involving Women With Lived Experience of Pelvic Organ Prolapse in Designing and Refining the Economic Components of a Health Technology Assessment
Sep 9, 2025, 16:22 PM -
A Contemporary Approach to Determining Cancer Patients Healthcare Resources Utilization
Sep 9, 2025, 16:22 PM -
Piloting a GenAI Agent for Structured Quality Appraisal of Network Meta-Analyses Using the ISPOR-AMCP-NPC Checklist
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Using Single-Operator Direct Visualization Cholangioscopy in the Management of Complex Bile Duct Stones in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Use of the ESMO-Magnitude of Clinical Benefit Scale to Guide HTA Recommendations on Coverage and Reimbursement for Cancer Medicines in Ireland: A Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco
Sep 9, 2025, 16:22 PM -
Cardiovascular Disease Risk-Reducing Strategies in Qatari Diabetes Patients: A Cost-Effectiveness Study
Sep 9, 2025, 16:22 PM -
Public Spending on Medicines Between 2018 and 2026: Lessons for Designing a New Financing Model in Portugal
Sep 9, 2025, 16:22 PM
